COMMUNIQUÉS West-GlobeNewswire

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
02/11/2026
SALT LAKE CITY, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three [...]
Abivax participera à plusieurs conférences investisseurs cet automne
02/11/2026
Abivax participera à plusieurs conférences investisseurs cet automne PARIS, France – le 2 novembre 2026 – 22 h 05 CET – Abivax SA (Euronext Paris : FR0012333284 – ABVX / Nasdaq: ABVX) (« Abivax » ou la « Société »), [...]
Abivax to Participate in Upcoming Fall Investor Conferences
02/11/2026
Abivax to Participate in Upcoming Fall Investor Conferences PARIS, France – November 2, 2026 – 10:05 PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage [...]
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2026 and Reaffirms 2026 Revenue Guidance
02/11/2026
Delivered ~20 % U.S. procedure volume growth in the third quarter Third Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $55.7 million, representing growth of 14.5% U [...]
Intuitive Appoints Aaron Martin to its Board of Directors
02/11/2026
SUNNYVALE, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the appointment of Aaron [...]
Medline announces participation in the 2026 Jefferies Global Healthcare Conference
02/11/2026
NORTHFIELD, Ill., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, chief executive officer, is scheduled to present at the Jefferies Global Healthcare Conference [...]
Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results
02/11/2026
Third quarter revenue of $206.7 million Third quarter diluted EPS of $(0.84); adjusted diluted EPS of $0.14 Third quarter operating cash flow of $46.4 million AMA CPT® Editorial Panel approved new Category I CPT codes [...]
Olema Oncology to Participate in Upcoming Investor Conferences
02/11/2026
SAN FRANCISCO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
DBV Technologies participera aux prochaines Conférences Investisseurs en novembre
02/11/2026
Châtillon, France, le 2 novembre (22 :30 CEST) 2026 DBV Technologies participera aux prochaines Conférences Investisseurs en novembre DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT [...]
DBV Technologies to Participate in Upcoming November Investor Conferences
02/11/2026
Châtillon, France, November 2, 2026 DBV Technologies to Participate in Upcoming November Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “Company”), a late- [...]
Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair
02/11/2026
New Phase 2 REC-4881 data presented at CGA-IGC in an expanded adult population aged 18 years and older show deep, durable polyp burden reductions in FAP, with activity throughout the GI tract and in larger, higher-risk [...]
MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy
02/11/2026
Webcast to highlight advancement of the randomized Phase 2 trial of agenT-797 in acute lung injury, the ARPA-H collaboration to advance deployable cell therapeutics, and new data released at the Society for [...]
Transactions under Novonesis’ share buyback program
02/11/2026
Please read the announcement in PDF Attachment 2026_26_Share_buyback
Quiet Communities Launches Free Science-based Resource Hub to Help Communities Address Data Center Noise
02/11/2026
Downloadable materials translate public health research and acoustical expertise into practical guidance for addressing noise throughout data center planning, construction and operation LINCOLN, Mass., Nov. 02, 2026 ( [...]
NeOnc Is Putting Two Brain Cancer Programs on the Global Stage
02/11/2026
Two Clinical Programs, a 500-Patient Vision, and a November that Could Be a Game-Changer for the Growing Wall Street Story DENVER, Nov. 02, 2026 (GLOBE NEWSWIRE) -- ( 247MarketNews.com ) — In a market where the latest [...]
Z Optics Receives Approval to Expand European Clinical Study of the Z+ Virtual Aperture IOL to Canada
02/11/2026
Following exceptional feedback from patients and physicians in Europe, the clinical trial of the Virtual Aperture intraocular lens will now open to clinical sites and patients in Canada RENO, Nev., Nov. 02, 2026 (GLOBE [...]
Coloplast A/S Announcement no. 10/2026 - Coloplast announces revised financial ambition towards 2030 and FY 2026/27 guidance
02/11/2026
Announcement no. 10/2026 Inside information Revised financial ambition towards 2030 includes 5-7% organic growth per year and an EBIT margin 1 in constant currencies in the mid-20% range over the period. Return on [...]
Coloplast A/S Announcement no. 11/2026 - 2025/26 Full-Year Financial Results
02/11/2026
1 October 2025 - 30 September 2026 Coloplast delivered 5% organic growth in Q4, driven by continued strength in Chronic Care and Interventional Urology. EBIT growth 1 in constant currencies was 0% and includes negative [...]
Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data
02/11/2026
WILMETTE, Ill., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum